Mesowatch

Available 24/7

949-565-6086
  • Pleural Mesothelioma
  • Exposure
  • Lawsuits
  • Contact
Select Page

Home > Resources

Report: Industry-Funded Asbestos Research Often Distorts Risks

Report: Industry-Funded Asbestos Research Often Distorts Risks

by Cameron Ayers | Feb 25, 2021

Industries and organizations that benefit from the continued mining and use of chrysotile asbestos regularly minimize the risks associated with the carcinogen via disinformation, the selective use of scientific data and policy influence, according to a new report. An...

read more
Targovax’s Mesothelioma Candidate Shines in Latest Survival Data

Targovax’s Mesothelioma Candidate Shines in Latest Survival Data

by Cameron Ayers | Feb 24, 2021

An immunotherapy candidate for mesothelioma continues to show promise in clinical trials, even before the trial has reached the halfway mark. Norwegian pharmaceutical company Targovax announced updated results Feb. 23 from its ongoing testing of ONCOS-102, a product...

read more
J&J Reserves Nearly $4 Billion for Talc-Based Lawsuits

J&J Reserves Nearly $4 Billion for Talc-Based Lawsuits

by Cameron Ayers | Feb 23, 2021

Manufacturing giant Johnson & Johnson has amassed a nearly $4 billion legal reserve to handle thousands of lawsuits, many claiming that its talcum powder products were tainted with asbestos, according to a regulatory filing. The company announced that its consumer...

read more
Proposed Talcum Powder Class-Action Suit Moves to Appeals Court

Proposed Talcum Powder Class-Action Suit Moves to Appeals Court

by Cameron Ayers | Feb 23, 2021

A planned class-action lawsuit against Johnson & Johnson and Bausch Health over alleged contaminants in their talcum powders — including asbestos — is going to the 9th U.S. Circuit Court of Appeals. An attorney representing the plaintiffs — Louisa Gutierrez and...

read more
OSHA Proposed Rules Look To Revise Asbestos Danger Labels

OSHA Proposed Rules Look To Revise Asbestos Danger Labels

by Cameron Ayers | Feb 22, 2021

Asbestos importers and removal firms would have to change their danger labels for the carcinogen under a recent federal proposal. A proposed rule from the Occupational Safety and Health Administration — a federal agency devoted to workplace safety — looks to rework...

read more
Researcher Awarded $2.5 Million to Develop Immunotherapy Response Test

Researcher Awarded $2.5 Million to Develop Immunotherapy Response Test

by Cameron Ayers | Feb 18, 2021

A planned study on immunotherapy’s effectiveness in mesothelioma cases got a major cash infusion this week, with the National Cancer Institute agreeing to shell out $2.5 million on the experimental research. Dr. Bryan Burt, who heads up the Baylor College of...

read more
EPA Shelves Risk Evaluation Model That Guided First Asbestos Review

EPA Shelves Risk Evaluation Model That Guided First Asbestos Review

by Cameron Ayers | Feb 17, 2021

The Environmental Protection Agency (EPA) is owning up to problems with its current approach to risk evaluations — as exemplified in the outcry over its 2020 asbestos review — and pledging to base future evaluations on “the best scientific data.” In a Feb. 16 release,...

read more
FDA to Fast Track Norwegian Firm’s Mesothelioma Candidate

FDA to Fast Track Norwegian Firm’s Mesothelioma Candidate

by Cameron Ayers | Feb 16, 2021

The Food and Drug Administration has granted a potential mesothelioma treatment special status to hasten its approval process. A candidate biologic for first-line treatment of malignant pleural mesothelioma — the most common form of the deadly disease — has been given...

read more
Genetic Expression Could Aid Diagnosis of Sarcomatoid Mesothelioma

Genetic Expression Could Aid Diagnosis of Sarcomatoid Mesothelioma

by Cameron Ayers | Feb 12, 2021

Genetic testing may be the key to distinguishing an unusually aggressive and sneaky type of mesothelioma from an unrelated condition. Chinese researchers have found that a protein emitted by the GATA3 gene is frequently detected in sarcomatoid malignant mesothelioma,...

read more
Mutated Gene Could Predict Chemoresistance in Mesothelioma Patients

Mutated Gene Could Predict Chemoresistance in Mesothelioma Patients

by Cameron Ayers | Feb 9, 2021

Mesothelioma’s frequent resistance to chemotherapy may be tied to a genetic mutation in some patients, according to a recent study. Researchers from Switzerland and Germany concluded that pleural mesothelioma patients with a mutated or missing BAP-1 gene all...

read more
Banner

Our Mission

Mesowatch mission serves as an industry watchdog and advocates for patients and families affected by asbestos by providing reliable and up-to-date news stories and information on asbestos use and exposure. We give voice to the victims and strive to effect real societal change.
  • Privacy Policy
  • Disclaimer

Explore Our Site

  • News
  • Blog
  • Settlements
  • Treatments
  • Our Team
  • About Us
  • Contact Us
  • Resources

Connect With Us

Call Toll-Free
949-565-6086
Mesowatch
email: [email protected]

Information provided by Mesowatch aims to provide legal and financial assistance and should not be considered a substitute for medical advice, treatment or diagnosis. Past performance and settlements do not guarantee or indicate the outcome of an individual case. Viewing this information or interacting with this website does not create an attorney-client relationship.

Asbestos Trust Funds

Begin Receiving Settlements from Asbestos Trust Funds in Just a Few Months.
1 
2 
3 
  • Start Receiving Settlements from Asbestos Trust Funds in Just a Few Months.
    • Claims Claims
    • Lawsuits Lawsuits
    • Settlement Settlement

    ...$30+ Billion Set Asside for Asbestos Victims

  • justice

    Our legal team will cover every base by and work with you through the entire process to ensure you receive the maximum amount of trust fund compensation to can help with medical, travel, treatment, and other related expenses.

  • justice

    Meet Greg

    Lead Attorney @MesoWatch

    “Allow me start working and protect your legal rights while you and your family are focusing on what matters most, your health.”

Search Form